Lithium use in octogenarians
β Scribed by Sabina Fahy; Brian A. Lawlor
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 50 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.452
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objectives
To assess the tolerability and sideβeffect profile of lithium use in a group of octogenarians attending a specialized lithium clinic.
Methods
This is a crossβsectional study looking at all patients of eighty years and over attending a lithium clinic. Charts were examined to assess renal function, thyroid function and level of sideβeffects during their course of lithium treatment in order to assess the tolerability of this medication in octogenarians.
Results
Twelve patients of 80 years and over (with an average age of 83.6 years) were taking lithium for an average period of 53.7 months. They had a mean serum level of 0.42βmmol/l. No patient had to discontinue lithium therapy because of sideβeffects, even though some patients did develop transient abnormalities of renal function. One patient developed diabetes insipidus. One female patient developed hypothyroidism.
Conclusions
Lithium was well tolerated and was administered safely to this cohort of octogenarians. Monitoring of serum lithium levels and kidney and thyroid function should preferably be done in the setting of a specialized lithium clinic. Copyright Β© 2001 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
In this study buspirone demonstrated efficacy and safety in the treatment of anxiety in elderly patients age 80 years or older. The results are consistent with data from earlier clinical and pharmacokinetic studies in elderly patients 60 years and older.